Inhibrx Biosciences director Jon Faiz Kayyem acquires $500,000 of common shares
INBX•Director reports indirect purchase of common shares
- Inhibrx Biosciences director Jon Faiz Kayyem reported an indirect purchase of 5,000 common shares at USD 100 each.
- The family trust’s indirect stake rose to 434,360 shares following the transaction.
